Sign In
Buy ARNA
$99.99
+0 (+0%)
At Close: May 27, 2022
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the completion of its previously announced underwritten public offering of 6,325,000 shares of its common stock at a price to the public of $
Moving Average Crossover Alert: Arena Pharmaceuticals
01:30pm, Monday, 01'st Jun 2020
Arena Pharmaceuticals, Inc. (ARNA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:30pm, Thursday, 28'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $50.00 per share. All of t
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:00am, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 27)
ADC Therapeutics SA (NYSE:...
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 27'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $250,000,000 of its common
Arena Pharmaceuticals Announces $250M Proposed Public Offering of Common Stock
12:00am, Wednesday, 27'th May 2020Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for Atopic Dermatitis, Provides Program Updates
12:30pm, Tuesday, 26'th May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 2b ADVISE trial evaluating etrasimod, an investigational next-generation, once-daily, oral
Arena Completes Full Enrollment Of Etrasimod Phase 2 ADVISE Trial For Atopic Dermatitis, Provides Program Updates
12:00am, Tuesday, 26'th May 2020Arena Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
08:30pm, Friday, 22'nd May 2020
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and lo
